Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid.
about
Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controlsDownregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes.Kynurenine 3-Monooxygenase: An Influential Mediator of NeuropathologyKynurenines in the mammalian brain: when physiology meets pathologyGlutamatergic synaptic dysregulation in schizophrenia: therapeutic implications.Role of the NMDA-receptor in Prepulse Inhibition in the Rat.Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder.Association study between kynurenine 3-monooxygenase gene and schizophrenia in the Japanese population.Pro-inflammatory cytokines reduce the proliferation of NG2 cells and increase shedding of NG2 in vivo and in vitro.A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder.The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression.Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis.Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia.Anterior thalamic lesions produce chronic and profuse transcriptional de-regulation in retrosplenial cortex: A model of retrosplenial hypoactivity and covert pathology.Exposure to Kynurenic Acid during Adolescence Increases Sign-Tracking and Impairs Long-Term Potentiation in Adulthood.Inhibitory action of clozapine on rat ventral tegmental area dopamine neurons following increased levels of endogenous kynurenic acid.Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia.The ketamine-like compound methoxetamine substitutes for ketamine in the self-administration paradigm and enhances mesolimbic dopaminergic transmission.Inhibition of Large Neutral Amino Acid Transporters Suppresses Kynurenic Acid Production Via Inhibition of Kynurenine Uptake in Rodent Brain.Cerebrospinal fluid kynurenic acid is associated with manic and psychotic features in patients with bipolar I disorder.Subchronic elevation of brain kynurenic acid augments amphetamine-induced locomotor response in mice.Cerebrospinal fluid kynurenic acid in male patients with schizophrenia – correlation with monoamine metabolites
P2860
Q24623659-9A33EDF4-6B52-407B-94C0-002E71A4CCDEQ24631189-CB43D20B-A454-4196-AA24-E7E996635997Q26782867-561ADE89-D5E4-445D-8FED-E90BE42CF798Q27003296-9AA4FDB5-C809-4321-8AF9-D393279E3E60Q30387014-019605F3-38AB-48D6-8B02-A83772BD846BQ30472936-11562271-142E-4DA5-80F2-ECAAB8921839Q33816563-8C748D85-33CD-4A09-BC9B-F1C6C2DDED67Q34529112-FAA076B0-995C-4C6D-96B2-EB007EB6A6A1Q35304641-BC7AD526-687D-4FE4-BBDC-D40D358F8A35Q37136385-862335DD-ED7D-4E85-88D5-317EAF24207AQ37186953-FCA01414-1942-43EA-BB23-B85400818472Q39130393-4306F457-B9AA-461F-AC94-F20DBCD94AF3Q41771344-F75A5471-8DF8-475C-AE13-E1E9A0DD9FB4Q42051311-E5069A52-B3BA-4C6A-8627-BAAF3D44B0F3Q43092673-A7A62463-A2B5-4677-8D7C-37A49C8698B0Q44515021-275651DA-80AC-4C6B-BE04-DE5394A3CEFBQ46364104-0C9BAB73-9985-4AA6-AADE-852C2095843FQ47448107-3D3577FB-492B-40E4-880B-29CC2A4C9559Q48055959-4AFC4117-1B73-448F-94C8-932155F7DD98Q48352892-78A417F1-9420-4100-A771-7D517B8A519BQ48909056-8C949EBE-455A-44FF-ABD9-EBA2B2E8450AQ57844012-7DD3E2C9-DD78-4BC7-9C20-EA3CD9D6E719
P2860
Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Increased phasic activity of d ...... of endogenous kynurenic acid.
@en
Increased phasic activity of d ...... of endogenous kynurenic acid.
@nl
type
label
Increased phasic activity of d ...... of endogenous kynurenic acid.
@en
Increased phasic activity of d ...... of endogenous kynurenic acid.
@nl
prefLabel
Increased phasic activity of d ...... of endogenous kynurenic acid.
@en
Increased phasic activity of d ...... of endogenous kynurenic acid.
@nl
P2860
P921
P1433
P1476
Increased phasic activity of d ...... of endogenous kynurenic acid.
@en
P2093
P2860
P356
10.1046/J.1365-201X.2002.00962.X
P577
2002-05-01T00:00:00Z